Clinical Trial Update: Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS) [Phase 3]

View source ↗

Summary

Open-label Phase 3 trial evaluating teduglutide in subjects with parenteral nutrition-dependent short bowel syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• Teduglutide (teduglutide)

Snippet

Sponsor: Shire | Conditions: Short Bowel Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2014-12-24